Korea to toughen rules on vendor audit

Published: 2009-12-29 06:59:00

Updated: 2009-12-29 06:59:00

Korea's drug watchdog says it plans to stiffen rules on the vendor audit system of a current Good Manufacturing Practice (cGMP) facility that manufactures drug components or finished products as the GMP for pharmaceutical active ingredients is to be implemented from next year.

However, officia...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK